Charmaine Roson - Philippines

“If the product is not listed in Annex A, then the intended use and ASEAN MDD classification rules will be used, and the CDRRHR will confirm or reclassify as needed during the 14 day pre-submission period.”

Charmaine Roson
Principal Consultant
Asia Actual Philippines

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Philippines Releases New Guidance on Class A Medical Devices

Published on: August 24th, 2021

FDA Releases List of 1,242 Medical Device Categories That Require a CMDN

To further help with clarifying the regulatory requirements for medical device manufacturers seeking market access in the Philippines, the FDA has released a list of Class A 1,242 product categories in Circular 2021-017 on August 16, 2021. Medical device manufacturers of Class A products specified in Annex A or under the ASEAN MDD, must obtain a Certificate of Medical Device Notification (CMDN). This must be done before manufacturing, distributing, importing, selling, and/or advertising the medical device. If the product is not listed in Annex A, then the intended use and ASEAN MDD classification rules will be used, and the CDRRHR will confirm or reclassify as needed during the 14 day pre-submission period. Classification of a medical device is subject to change if features of a product, such as intended use or duration of use, were to change.

This guidance will take effect fifteen (15) days after its publication in a newspaper of general circulation and when three (3) certified copies are filed to the UP Law Center.

Come Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia and with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests for the Philippines.

Blog Posts

Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Read more
Thai FDA Documentation Exemptions for Concise and Full Regulatory Pathways

Thai FDA Regulatory Documentation Exemptions

March 12, 2024: the Thai FDA released draft guidance updating the list of required documentation for Full and Concise Evaluation. For manufacturers registering a medical device in Thailand, certain documents are no longer required.
Read more
Hong Kong MDD adds Singapore HSA to Reference Country List

Hong Kong MDD Adds Singapore as Reference Country

Starting April 2nd, 2024, the Hong Kong Medical Device Division (MDD) accepts, on a regular basis, the marketing approvals obtained from the the Health Sciences Authority (HSA) of Singapore as a support of compliance of medical device to the "Essential Principles of Safety and Performance of Medical Devices" (Technical Reference: TR-004) under MDACS.
Read more